These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3178517)

  • 21. [The progression rates of different morphological forms of chronic glomerulonephritis in the pre-azotemia period (is the morphological form of chronic glomerulonephritis the factor that determines the prognosis?)].
    Riabov SI; Dobronravov VA
    Ter Arkh; 1994; 66(6):15-8. PubMed ID: 7940356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronically occurring glomerular nephropathies in children (the morphological and immunological characteristics and morphogenetic problems)].
    Klembovskiĭ AI
    Arkh Patol; 1980; 42(7):29-39. PubMed ID: 7417020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of immunoglobulins and complements in formaldehyde-fixed and paraffin-embedded renal biopsy tissues; an adjunct for diagnosis of glomerulonephritis.
    Chowdhury AR; Ehara T; Higuchi M; Hora K; Shigematsu H
    Nephrology (Carlton); 2005 Jun; 10(3):298-304. PubMed ID: 15958046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of the clinical course of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Klin Med (Mosk); 1996; 74(1):17-20. PubMed ID: 8648997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The prognostic significance of the morphological type of chronic glomerulonephritis and of the tubulointerstitial changes depending on the clinical type of the disease].
    Ratner MIa; Fedorova ND
    Ter Arkh; 1997; 69(6):10-3. PubMed ID: 9297263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Morphological changes in the kidney glomeruli in gout].
    Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Diadyk AI; Shevchenko NI
    Arkh Patol; 1986; 48(9):54-8. PubMed ID: 3789948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The tubulointerstitial changes in different clinical and morphological types of chronic glomerulonephritis].
    Ratner MIa; Fedorova ND; Makurov AI
    Urol Nefrol (Mosk); 1997; (2):16-9. PubMed ID: 9206875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of the FcgammaRIIalpha IgG receptor in patients with lupus nephritis and glomerulopathy.
    Gelmetti AP; Freitas AC; Woronik V; Barros RT; Bonfá E; Monteiro RC
    J Rheumatol; 2006 Mar; 33(3):523-30. PubMed ID: 16511922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic dilemmas in atypical postinfectious glomerulonephritis.
    Sotsiou F; Dimitriadis G; Liapis H
    Semin Diagn Pathol; 2002 Aug; 19(3):146-59. PubMed ID: 12180635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness.
    Bergijk EC; Baelde HJ; de Heer E; Killen PD; Bruijn JA
    Exp Nephrol; 1995; 3(6):338-47. PubMed ID: 8528678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-deoxyribonucleic acid antibodies in podagra].
    Nikolenko IuI; Siniachenko OV; Diadyk AI
    Revmatologiia (Mosk); 1989; (2):30-5. PubMed ID: 2678395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis.
    Ono T; Liu N; Makino T; Nogaki F; Nomura K; Muso E; Shimizu F; Honda G; Kita T
    J Pathol; 2004 Oct; 204(2):229-38. PubMed ID: 15376264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The heterologous immune complex glomerulonephritis. A dose dependent glomerulonephritis with acute, latent and chronic phases in a long-term study.
    Iversen BM; Matre R; Ofstad J
    Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):241-50. PubMed ID: 6217719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
    Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced glomerular procoagulant activity and fibrin deposition in rats with mercuric chloride-induced autoimmune nephritis.
    Kanfer A; de Prost D; Guettier C; Nochy D; Le Floch V; Hinglais N; Druet P
    Lab Invest; 1987 Aug; 57(2):138-43. PubMed ID: 3475499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.
    Lin KC; Lin HY; Chou P
    J Rheumatol; 2000 Jun; 27(6):1501-5. PubMed ID: 10852278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesangial proliferative glomerulonephritis with deposits of anti-nicotinic acetylcholine receptor antibody in a patient with myasthenia gravis.
    Mitsui T; Okada K; Kuhara T; Hashizume T; Okazaki S; Kawajiri M; Matsumoto T
    J Clin Neurosci; 2001 Sep; 8(5):454-6. PubMed ID: 11535018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.